Director: Mary Garrity

Case Western Reserve University
Startup Officer: Stephanie Weidenbecher

Technology Area:
  • Pharmaceuticals and Medical

Red5 Pharmaceuticals, LLC is an emerging start-up company based in Cleveland, Ohio focusing on the development of innovative therapeutic and diagnostic agents against cancer. Our company performs the chemical synthesis and pharmaceutical testing of non-natural nucleosides as novel anti-cancer agents against hematological cancers and solid tumors. Red5 is also developing the KRunTM kit – a companion diagnostic assay that can predict in 1 day whether or not a patient’s cancer will respond to a specific chemotherapy BEFORE treatment. This provides a significant advancement compared to the standard of care which can take up to 2 months to determine if a treatment is effective or not.

Articles to be posted soon.